{
Thermo Fisher Scientific Inc.

Companies

}
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-022025-04-021111100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-022025-04-021111100
Download SVG
Download PNG
Download CSV

nanorobots in healthcare market projected to reach 13.4 billion by 2032

The global Nanorobots in the Healthcare market is projected to reach USD 13.4 billion by 2032, growing at a CAGR of 18.35% from 2024 to 2032. Key players like Abbott Laboratories and Medtronic are driving growth through partnerships and product innovations across various applications and regions. The market analysis includes detailed segmentation by application, type, end use, and material, alongside insights into competitive dynamics and regional trends.
openPR.com
United States Dollar Medtronic Defined Contribution Plan Master Trust Koninklijke Philips N.V. Siemens Energy AG Nanosys Mitsubishi Electric Corporation Thermo Fisher Scientific Inc. Becton, Dickinson and Company F. Hoffmann-La Roche SA NanoString Technologies Inc. Zebra Medical Vision Johnson and Johnson IBM 401(k) Plan Trust USA GBR Medtronic Abbot Laboratories F. HoffmannLa Roche CureMetrix NanoString Technologies Show more
Technology & Innovation, Market Report
10:08 12.11.2024

global immunoassay market growth driven by innovative technologies and rising demand

The global immunoassay market is projected to grow significantly, driven by advancements in enzyme immunoassays, which held over 58.2% market share in 2022. The infectious disease testing segment is expected to expand at a CAGR of 5.6%, fueled by rising global incidences of diseases like HIV and hepatitis. North America leads the market with over 36.2% of revenues, supported by advanced healthcare infrastructure and a high prevalence of chronic diseases.
Spherical Insights
United States Dollar SIEMENS HEALTHINEERS BioMerieux SA Abbott Laboratories Danaher Company Quidel Company Ortho-Clinical Diagnostics Inc. Sysmex Company Bio-Rad Laboratories, Inc. Becton, Dickinson and Company F. Hoffmann-La Roche AG Thermo Fisher Scientific Inc. USA CAN MEX DEU GBR FRA ITA ESP RUS CHN JPN IND KOR AUS BRA ARG ARE SAU QAT ZAF Show more
Healthcare, Market Report
09:51 08.11.2024

global biobanking market growth driven by stem cell research and automation

The global biobanking market is projected to grow significantly, driven by advancements in cryopreservation and automation, with stem cells expected to dominate the market. Europe is anticipated to hold the largest share due to its robust healthcare infrastructure, while Asia-Pacific is set for the fastest growth, fueled by increased investments and a rising prevalence of chronic diseases. Key developments include substantial funding for the UK Biobank and initiatives to enhance global access to biomedical data.
Spherical Insights
Qiagen N.V. Thermo Fisher Scientific Inc. Becton, Dickinson and Company Merck KGaA Danaher Company CHN FRA ESP BRA KOR IND ZAF ITA SAU ARG CAN USA RUS JPN MEX GBR DEU ARE AUS QAT Thermo Fisher Scientific Inc. Becton Dickinson and Company (BD) Charles River Laboratories Merck KGaA Danaher Company Show more
Healthcare, Market Report
21:57 06.11.2024

global clinical trials market poised for significant growth through 2032

WuXi ATU will manufacture and test WU-NK-101, a groundbreaking cell therapy for cancer patients. The global clinical trials market is projected to reach $93.42 billion by 2032, driven by rising pharmaceutical R&D investments and an increasing number of trials, particularly in Phase III and autoimmune indications. Major players include IQVIA, LabCorp, and WuXi AppTec, focusing on innovative therapies and AI integration to enhance drug discovery efficiency.
Spherical Insights
United States Dollar WuXi AppTec Co., Ltd. Syneos Health Icon plc PPD Inc. Thermo Fisher Scientific Inc. CHN FRA ESP BRA KOR IND ZAF ITA SAU ARG CAN USA RUS JPN MEX GBR DEU ARE AUS QAT Show more
Healthcare, Market Report
21:35 06.11.2024

ipr001 begins first human trial as global crispr market expands rapidly

SNIPR BIOME ApS has initiated the first human clinical trial for SNIPR001, targeting E. coli colonization in healthy volunteers, set to begin in the first half of 2022. The global CRISPR technology market is projected to grow significantly, with North America leading in market share, driven by advancements in biomedical applications and increasing research activities.
Spherical Insights
United States Dollar Integrated DNA Technologies Inc. Mirus Bio LLC Sangamo Therapeutics, Inc. CRISPR Therapeutics AG Genscript Abbott Laboratories Merck & Co., Inc. NEW England Biolabs Inc. Thermo Fisher Scientific Inc. Lonza Group AG Takara Bio Inc. ABio-Rad Laboratories Inc USA DEU MEX ITA ARG AUS ZAF IND RUS JPN KOR GBR BRA CAN ARE ESP CHN Show more
Healthcare, Market Report
20:26 28.10.2024

myoglobin market growth driven by cardiovascular disease awareness and diagnostics

The global myoglobin market, valued at $101.5 million in 2022, is projected to grow at a CAGR of 4.32% through 2030, driven by rising cardiovascular disease awareness and increased health department investments. North America leads the market, with the diagnostic segment holding the largest share due to heightened demand for early diagnosis and intervention. Key players include Merck KGaA, Abbott, and Thermo Fisher Scientific, focusing on innovative products and technologies.
Market Research Reporting & Analysis Agency in India
United States Dollar Abbott-Action Inc. Thermo Fisher Scientific Inc. F. Hoffmann-La Roche SA Merck KGaA Siemens Healthcare Private Limited USA Abbott F. Hoffmann-La Roche SA Merck KGaA Thermo Fisher Scientific Inc. Siemens Healthcare Private Limited Show more
Healthcare, Market Report
13:22 25.10.2024

healthcare refractometer market poised for significant growth through 2031

The Healthcare Refractometer market is poised for significant growth from 2024 to 2031, driven by increased applications in medical diagnostics and innovations from key players like Thermo Fisher Scientific and Mettler-Toledo. North America is expected to dominate the market share, supported by major pharmaceutical companies. The report highlights the importance of competitive intelligence, real-time pipeline analysis, and tailored solutions to meet evolving healthcare needs.
openPR.com
United States Dollar Anton Paar GmbH AMETEK, Inc. Atago Co., Ltd. Mettler-Toledo International Inc. Thermo Fisher Scientific Inc. USA Anton Paar GmbH Inc. AMETEK Atago Co. Mettler-Toledo International Inc. Thermo Fisher Scientific Inc. Ltd. Show more
Healthcare, Market Report
08:58 22.10.2024

bioreactors market poised for significant growth through 2031 with key players

The Bioreactors Market is projected to experience significant growth from 2024 to 2031, driven by increased demand and technological advancements. A comprehensive report analyzes market size, trends, competitive landscape, and future growth prospects, highlighting key players like GE Healthcare and Pall Corporation. The study also delves into market segmentation, consumption patterns, and pricing strategies, providing valuable insights for stakeholders.
EIN News
United States Dollar Thermo Fisher Scientific Inc. Sartorius AG BBI Merck KGaA Pall Corporation GE HealthCare Technologies Inc. Thermo Fisher Scientific Inc. GE Healthcare Infors AG Merck KGaA Pall Corporation Show more
Healthcare, Market Report
13:09 21.10.2024

merck kgaa navigates mixed signals amid growth in semiconductor materials

MERCK KGAA's Capital Markets Day sparked a 7.6% market rise, despite dampened pharmaceutical expectations following setbacks in drug development. The Electronics division, particularly Semiconductor Materials, is projected to grow sales by 5-9% annually, while pharmaceuticals anticipate slight growth through licensing. Analysts remain optimistic, with target prices from DEUTSCHE BANK at €180 and GOLDMAN SACHS at €205, reflecting a calming effect from the event.
FinanzNachrichten.de
Euro Thermo Fisher Scientific Inc. Merck KGaA BB Biotech AG DEU CHN Belen Garijo Helmut Gellermann Show more
Finance & Economy, Market Report
18:33 18.10.2024

global cdmo market projected to reach 279 billion by 2026

The global contract development and manufacturing organization (CDMO) market, valued at USD 130.8 billion in 2018, is projected to reach USD 278.98 billion by 2026, growing at a CAGR of 10.0%. This growth is driven by rising demand for novel therapies, increasing complexity of treatments, and strategic partnerships between pharmaceutical companies and CDMOs. Key trends include market consolidation and significant investments in infrastructure, while challenges such as stringent regulations may hinder growth.
fortunebusinessinsights.com
United States Dollar Recipharm AB Baxter International Inc. Catalent, Inc. Thermo Fisher Scientific Inc. CHE USA Paragon Bio Services Cambrex Corporation Avista Pharma Solutions Inc Catalent Recipharm AB Show more
Healthcare, Market Report
09:00 14.10.2024
Trending
Subcategory
Corporate News Startups & Entrepreneurship Industry Trends Global Trade Developments Stock Market Updates Industry Mergers & Acquisitions Private Equity Deals Government Economic Policies Supply Chain Management Fintech Startups Venture Capital Investments Retail and Consumer Goods Inflation and Monetary Impact Workplace Trends Energy Sector Developments Finance Mergers & Acquisitions Central Bank Actions CEO Changes Emerging Startups Crypto Policies and Governance
Countries:
IND USA CHN ARE JPN SAU EGY SGP HKG TWN KOR IDN MYS THA BHR ISR PHL TGO AUS FRA
Companies:
Apple Inc. NIO Inc. Nikkei 225 Google Inc. Nintendo Co., Ltd. Grab2Go AS OLA ELECTRIC MOBILITY LTD Eurasia Groupe SA British International Investment plc XPeng Inc. Li Auto Inc. Morgan Stanley Taiwan Semiconductor Manufacturing Company Limited VFS Global AG LARGAN Precision Co.,Ltd S&P/ASX 200 HANG SENG BANK Delhivery Limited Ecom Express Ltd. Arazul Sequoia Capital FIM C Priv
Currencies:
United States Dollar Indian Rupee Euro Chinese Yuan Japanese Yen United Arab Emirates Dirham New Taiwan Dollar Indonesian Rupiah Saudi Riyal Offshore Chinese Yuan Hong Kong Dollar Malaysian Ringgit Filipino Peso West African CFA Franc South Korean Won Thai Baht Mexican Peso Croatian Kuna Bahraini Dinar Egyptian Pound
People:
Donald Trump Jerome Powell Joe Biden Nancy Wei Anwar Ibrahim James Smith George Davis Ariel Maislos Itamar Falcon Michael Ehrlich Youma Fall Christian Palouki Rahul Jain Ahmed Obaid Rodolphe Saadé Sahil Barua Pam Bondi Serene Sia Hana Raja Hsu Ken Ooi

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.